| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA471: Eluxadoline for treating irritable bowel syndrome with diarrhoea |
|
Medicine details |
|
| Medicine name | eluxadoline (Truberzi®) |
| Formulation | 75 mg, 100 mg film-coated tablet |
| Reference number | 2687 |
| Indication | In adults for the treatment of irritable bowel syndrome with diarrhoea |
| Company | Allergan Ltd |
| BNF chapter | Gastro-intestinal system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 31/08/2016 |
| NICE guidance | TA471: Eluxadoline for treating irritable bowel syndrome with diarrhoea |